anubhai
Back OfficeNippon India Pharma Fund (Bonus)
Summary
| Fund Name | Nippon India Mutual Fund |
| Scheme Name | Nippon India Pharma Fund (Bonus) |
| AMC | Nippon India Mutual Fund |
| Type | Open |
| Category | Equity - Pharma |
| Launch Date | 10-May-2004 |
| Fund Manager | Sailesh Raj Bhan |
| Net Assets(Rs. cr) | 8,635.75 |
NAV Graph
| One Month | Three Month | Six Month | One Year | Three Year | Five Year |
Latest Payouts
| Dividends | Bonus |
|---|
Performance
| 1 Week (%) | 1 Month (%) | 3 Month (%) | 6 Month (%) | 1 Year (%) | 3 Year (%) | 5 Year (%) | Since INC (%) | |
|---|---|---|---|---|---|---|---|---|
| Scheme Return | -0.11 | -1.66 | 7.49 | 5.33 | 3.86 | 20.50 | 12.48 | 19.79 |
| Category Avg | -0.09 | 0.34 | 11.50 | 8.18 | 8.51 | 22.65 | 14.06 | 15.26 |
| Category Best | 0.90 | 3.31 | 15.70 | 14.80 | 17.67 | 26.50 | 16.81 | 29.61 |
| Category Worst | -1.09 | -1.66 | 4.81 | -0.17 | 0.46 | 18.26 | 10.26 | -0.55 |
Asset Allocation
Holdings
| Company Name | % Hold |
|---|---|
| Sun Pharma.Inds. | 13.35 |
| Lupin | 7.31 |
| Dr Reddy's Labs | 6.72 |
| Cipla | 6.16 |
| Divi's Lab. | 5.80 |
| Apollo Hospitals | 5.20 |
| Mankind Pharma | 3.94 |
| Medplus Health | 3.68 |
| Sai Life | 3.43 |
| Vijaya Diagnost. | 3.21 |
| Ajanta Pharma | 3.21 |
| Max Healthcare | 2.97 |
| Thyrocare Tech. | 2.56 |
| Ipca Labs. | 2.41 |
| Glaxosmi. Pharma | 2.34 |
| Aurobindo Pharma | 2.32 |
| Abbott India | 2.31 |
| Gland Pharma | 2.09 |
| Alkem Lab | 2.06 |
| Dr Lal Pathlabs | 1.90 |
| Narayana Hrudaya | 1.81 |
| Syngene Intl. | 1.79 |
| Pfizer | 1.69 |
| Emcure Pharma | 1.47 |
| Suraksha Diagno. | 1.29 |
| Fortis Health. | 1.19 |
| Sanofi Consumer | 1.14 |
| Anthem Bioscienc | 0.93 |
| Akums Drugs | 0.92 |
| Sanofi India | 0.83 |
| Biocon | 0.73 |
| Astrazeneca Phar | 0.63 |
| Indoco Remedies | 0.45 |
| Concord Biotech | 0.14 |
| TREPS | 2.16 |
| Net CA & Others | -0.14 |
| C C I | 0.00 |
